483 related articles for article (PubMed ID: 34503531)
1. Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent.
Hedrick SL; Luo D; Kaska S; Niloy KK; Jackson K; Sarma R; Horn J; Baynard C; Leggas M; Butelman ER; Kreek MJ; Prisinzano TE
J Biomed Sci; 2021 Sep; 28(1):62. PubMed ID: 34503531
[TBL] [Abstract][Full Text] [Related]
2. Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids.
Elder HJ; Walentiny DM; Beardsley PM
Pharmacol Biochem Behav; 2023 Aug; 229():173601. PubMed ID: 37414364
[TBL] [Abstract][Full Text] [Related]
3. Searching for Synthetic Opioid Rescue Agents: Identification of a Potent Opioid Agonist with Reduced Respiratory Depression.
Vu LY; Luo D; Johnson K; Denehy ED; Songrady JC; Martin J; Trivedi R; Alsum AR; Shaykin JD; Chaudhary CL; Woloshin EJ; Kornberger L; Bhuiyan N; Parkin S; Jiang Q; Che T; Alilain W; Turner JR; Bardo MT; Prisinzano TE
J Med Chem; 2024 Jun; 67(11):9173-9193. PubMed ID: 38810170
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal Antibodies for Combating Synthetic Opioid Intoxication.
Smith LC; Bremer PT; Hwang CS; Zhou B; Ellis B; Hixon MS; Janda KD
J Am Chem Soc; 2019 Jul; 141(26):10489-10503. PubMed ID: 31187995
[TBL] [Abstract][Full Text] [Related]
5. Vaccine blunts fentanyl potency in male rhesus monkeys.
Tenney RD; Blake S; Bremer PT; Zhou B; Hwang CS; Poklis JL; Janda KD; Banks ML
Neuropharmacology; 2019 Nov; 158():107730. PubMed ID: 31369740
[TBL] [Abstract][Full Text] [Related]
6. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
7.
Hiranita T; Ho NP; France CP
J Pharmacol Exp Ther; 2024 Feb; ():. PubMed ID: 38409115
[TBL] [Abstract][Full Text] [Related]
8. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
[TBL] [Abstract][Full Text] [Related]
10. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
Kuo A; Wyse BD; Meutermans W; Smith MT
Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546
[TBL] [Abstract][Full Text] [Related]
11. Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice.
Santos EJ; Banks ML; Negus SS
J Pharmacol Exp Ther; 2022 Jul; 382(1):44-53. PubMed ID: 35489781
[TBL] [Abstract][Full Text] [Related]
12. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest.
Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z
Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413
[TBL] [Abstract][Full Text] [Related]
13. Isobolographic analysis of the opioid-opioid interactions in a tonic and a phasic mouse model of induced nociceptive pain.
Miranda HF; Noriega V; Zanetta P; Prieto JC; Prieto-Rayo JC; Aranda N; Sierralta F
J Biomed Sci; 2014 Jul; 21(1):62. PubMed ID: 25017386
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression.
Varshneya NB; Hassanien SH; Holt MC; Stevens DL; Layle NK; Bassman JR; Iula DM; Beardsley PM
Pharmacol Biochem Behav; 2023 May; 226():173572. PubMed ID: 37236405
[TBL] [Abstract][Full Text] [Related]
17. Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptors.
Patkar KA; Wu J; Ganno ML; Singh HD; Ross NC; Rasakham K; Toll L; McLaughlin JP
J Pharmacol Exp Ther; 2013 Sep; 346(3):545-54. PubMed ID: 23853171
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Profiling of Antifentanyl Monoclonal Antibodies in Combination with Naloxone in Pre- and Postexposure Models of Fentanyl Toxicity.
Baehr CA; Wu MM; Pandit SG; Arias-Umana J; AuCoin D; Pravetoni M
J Pharmacol Exp Ther; 2022 May; 381(2):129-136. PubMed ID: 35153198
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone.
Schwienteck KL; Blake S; Bremer PT; Poklis JL; Townsend EA; Negus SS; Banks ML
Drug Alcohol Depend; 2019 Nov; 204():107501. PubMed ID: 31479865
[TBL] [Abstract][Full Text] [Related]
20. Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide.
Vandeputte MM; Tsai MM; Chen L; Glatfelter GC; Walther D; Stove CP; Shi L; Baumann MH
Drug Alcohol Depend; 2023 Aug; 249():109939. PubMed ID: 37276825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
